APR-1051, a Next-Generation WEE1 Inhibitor, Enhances the Efficacy of Immunotherapy in Head and Neck Squamous Cell Carcinoma

APR-1051 - Aprea

https://eppro02.ativ.me/web/page.php?page=IntHtml&project=AHNS26&id=153845

Mutsuki Kawabe, DDS, PhD; Tsung-You Tsai, MD; Jennifer Anderson, MD, PhD; Arisa Nishikawa Kaga, DDS, PhD; Kento Okamoto, DDS, PhD; Sofia Cortes; Ratna Veeramachaneni, PhD; Andrew G Sikora, MD, PhD; Jeffrey N Myers, MD, PhD; Abdullah A Osman, PhD

Jul 14, 2026